BRPI0514458A - triazolbenzodiazepinas e seu uso como antagonistas de vasopressina - Google Patents

triazolbenzodiazepinas e seu uso como antagonistas de vasopressina

Info

Publication number
BRPI0514458A
BRPI0514458A BRPI0514458-2A BRPI0514458A BRPI0514458A BR PI0514458 A BRPI0514458 A BR PI0514458A BR PI0514458 A BRPI0514458 A BR PI0514458A BR PI0514458 A BRPI0514458 A BR PI0514458A
Authority
BR
Brazil
Prior art keywords
premature
ring
alkyl
vasopressin antagonists
triazolbenzodiazepines
Prior art date
Application number
BRPI0514458-2A
Other languages
English (en)
Inventor
Patrick Stephen Johnson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0418980A external-priority patent/GB0418980D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of BRPI0514458A publication Critical patent/BRPI0514458A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

TRIAZOLBENZODIAZEPINAS E SEU USO COMO ANTAGONISTAS DE VASOPRESSINA Compostos de fórmula (I), ou derivados farmaceuticamente aceitáveis destes, em que R representa H, alquila C~ 1~-6~, SO~ 2~R¬ 1¬, SO~ 2~NR¬ 1¬R¬ 2¬, ou COR¬ 1¬; R¬ 1¬ e R¬ 2¬ representam, independentemente, alquila C~ 1-6~; e o anel A representa um anel fenila ou um anel piridinila, podem ser úteis no tratamento de ansiedade, doença cardiovascular (incluindo angina, aterosclerose, hipertensão, insuficiência cardíaca, edema, hipernatremia), dismenorréia, (primária e secundária), endometriose, êmese (incluindo cinetose), crescimento intra-uterino retardado, inflamação (incluindo artrite reumatólde), dor intermenstrual, pré-eclâmpsia, ejaculação precoce, trabalho de parto prematuro (antes do tempo) e doença de Raynaud.
BRPI0514458-2A 2004-08-25 2005-08-12 triazolbenzodiazepinas e seu uso como antagonistas de vasopressina BRPI0514458A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0418980A GB0418980D0 (en) 2004-08-25 2004-08-25 Triazole compounds useful in therapy
US61660104P 2004-10-05 2004-10-05
PCT/IB2005/002711 WO2006021882A1 (en) 2004-08-25 2005-08-12 Triazolobenzodiazepines and their use as vasopressin antagonists

Publications (1)

Publication Number Publication Date
BRPI0514458A true BRPI0514458A (pt) 2008-06-10

Family

ID=35355092

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0514458-2A BRPI0514458A (pt) 2004-08-25 2005-08-12 triazolbenzodiazepinas e seu uso como antagonistas de vasopressina

Country Status (7)

Country Link
US (1) US7456170B2 (pt)
EP (1) EP1784408A1 (pt)
JP (1) JP2008510789A (pt)
BR (1) BRPI0514458A (pt)
CA (1) CA2578370A1 (pt)
MX (1) MX2007002248A (pt)
WO (1) WO2006021882A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2356123T1 (sl) * 2008-11-13 2013-01-31 F. Hoffmann-La Roche Ag Piro-5,6-dihidro-4h-2,3,5,10b-tetraaza-benzo(e)azuleni
SG171742A1 (en) * 2008-11-18 2011-07-28 Hoffmann La Roche Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
EP2370441B1 (en) 2008-11-28 2013-09-11 F. Hoffmann-La Roche AG Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin v1a receptor antagonists
US8420633B2 (en) * 2010-03-31 2013-04-16 Hoffmann-La Roche Inc. Aryl-cyclohexyl-tetraazabenzo[e]azulenes
US8461151B2 (en) * 2010-04-13 2013-06-11 Hoffmann-La Roche Inc. Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes
US8492376B2 (en) 2010-04-21 2013-07-23 Hoffmann-La Roche Inc. Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes
US8481528B2 (en) 2010-04-26 2013-07-09 Hoffmann-La Roche Inc. Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
US8513238B2 (en) * 2010-05-10 2013-08-20 Hoffmann-La Roche Inc. Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes
US8828989B2 (en) * 2011-09-26 2014-09-09 Hoffmann-La Roche Inc. Oxy-cyclohexyl-4H,6H-5-oxa-2,3,10b-triaza-benzo[E]azulenes as V1A antagonists
MX350844B (es) 2012-03-06 2017-09-22 Pfizer Derivados macrocíclicos para el tratamiento de enfermedades proliferativas.
CN105492010B (zh) * 2013-08-19 2020-01-03 豪夫迈·罗氏有限公司 用于治疗相移睡眠障碍的V1a拮抗剂
MX2016006558A (es) 2013-12-05 2016-08-03 Hoffmann La Roche Sistesis de trans-8-cloro-5-metil-1-[4-(piridin-2-iloxi)-ciclohexi l]-5,6-dihidro-4h-2,3,5,10b-tetraaza-benzo[e]azuleno y formas cristalinas del mismo.
TW201938171A (zh) 2017-12-15 2019-10-01 匈牙利商羅特格登公司 作為血管升壓素Ｖ１ａ受體拮抗劑之三環化合物
HU231206B1 (hu) * 2017-12-15 2021-10-28 Richter Gedeon Nyrt. Triazolobenzazepinek

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999006409A1 (en) * 1997-07-30 1999-02-11 American Home Products Corporation Tricyclic vasopressin agonists
MXPA04007995A (es) * 2002-02-19 2004-11-26 Teva Pharma Desolvatacion de solvatos de hemicalcio de atorvastatina.
US7119088B2 (en) * 2003-02-19 2006-10-10 Pfizer Inc. Triazole compounds useful in therapy
GB0303852D0 (en) * 2003-02-19 2003-03-26 Pfizer Ltd Triazole compounds useful in therapy

Also Published As

Publication number Publication date
EP1784408A1 (en) 2007-05-16
US7456170B2 (en) 2008-11-25
MX2007002248A (es) 2008-10-02
JP2008510789A (ja) 2008-04-10
US20070249585A1 (en) 2007-10-25
CA2578370A1 (en) 2006-03-02
WO2006021882A1 (en) 2006-03-02

Similar Documents

Publication Publication Date Title
BRPI0514458A (pt) triazolbenzodiazepinas e seu uso como antagonistas de vasopressina
BRPI0510340A (pt) derivados de 3-heterociclil-4-feniltriazol como inibidores do receptor via da vasopressina
NO20062098L (no) Faststofftilstandmontelukast
DE60230327D1 (de) Polymorphe von clopidogrel-hydrogensulfat
EA200601849A1 (ru) 4-фениламинохиназолин-6-ил-амиды
ATE442356T1 (de) 1-essigsäureindolderivate mit pgd2- antagonistischer wirkung
ATE490253T1 (de) Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen
EA200600925A1 (ru) Производные триазола в качестве антагонистов вазопрессина
HRP20050070B1 (hr) 3-2-[1-(4-(n-((4-metil-piperazin-1-il)-metilkarbonil)-n-metil-amino)-anilino)-1-fenil-metilen]-6-metoksikarbonil-2-indolinon-monoetansulfonat i njegova primjena kao farmaceutskog pripravka
WO2006121528A3 (en) Ring closing and related methods and intermediates
CY1107167T1 (el) Ανταγωνιστες στον ταχυκινινικο υποδοχεα της υδροϊσοϊνδολινης
DK1776377T3 (da) Nyt steroid til FXR
PE20080059A1 (es) Quinazolinas para la inhibicion de pdk1
NO331174B1 (no) Substituerte 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazinderivater og deres anvendelse som neurokininantagonister
BRPI0506848A (pt) composto,uso do mesmo, formulação farmacêutica e produto farmacêutico
NO20070588L (no) Piperidinderivater som NK1-antagonister.
NO20055535L (no) Makrodkonjugater med anti-inflammatorisk aktivitet
PL367094A1 (en) Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
NO20081365L (no) Ny krystallinsk form av et pyridazino[4,5-b]indolderivat
CO5271666A1 (es) Derivados de pirimidina
MX2007007152A (es) Antagonista de naurocinina-1 con anillo en puente.
BRPI0506994A (pt) derivados de triazol que inibem a atividade antagonista da vasopressina
NO20064012L (no) Kjemisk prosess
PE20060942A1 (es) Derivados nonadepsipeptidos acilados ii como agentes bactericidas
DK1948626T3 (da) Fremgangsmåde til fremstilling af delmopinol og derivater deraf

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.